Perrigo (PRGO) Equity Average (2013 - 2026)
Perrigo (PRGO) reported Equity Average of $2.7 billion for Q1 2026, down 37.42% year-over-year from $4.3 billion in Q1 2025, and down 26.38% quarter-over-quarter from $3.7 billion in Q4 2025.
Perrigo (PRGO) Equity Average (2013 - 2026) Analysis & Trends
Perrigo (PRGO) has 14 years of Equity Average data on file, last reported at $2.7 billion in Q1 2026.
- Equity Average for Q1 2026 came in at $2.7 billion, down 37.42% year-over-year; the trailing twelve-month figure through Mar 2026 was $2.7 billion (down 37.42% YoY), and the FY2025 annual result was $3.6 billion, down 20.16% from the prior year.
- Equity Average declined to $2.7 billion in Q1 2026 per PRGO's latest filing, from $3.7 billion in the prior quarter.
- Over five years, Equity Average peaked at $5.1 billion in Q2 2022 and troughed at $2.7 billion in Q1 2026.
- A 5-year average of $4.5 billion and a median of $4.7 billion in 2022 frame the typical range for Equity Average.
- The sharpest annual moves came in 2023 and 2026: Equity Average grew 1.42% in 2023, then sank 37.42% in 2026.
- A 5-year view of Equity Average shows it stood at $4.7 billion in 2022, then gained by 0.65% to $4.8 billion in 2023, then declined by 6.53% to $4.4 billion in 2024, then retreated by 16.92% to $3.7 billion in 2025, then decreased by 26.38% to $2.7 billion in 2026.
- Business Quant data shows PRGO's Equity Average at $2.7 billion in Q1 2026, $3.7 billion in Q4 2025, and $4.5 billion in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Equity Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | 8.07 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 3.32 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | 6.50 Bn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | 409.63 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 3.33 Bn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | 6.52 Bn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | 1.79 Bn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | 493.55 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 1.15 Bn |
| 10 | Perrigo | 1.55 Bn | 1.19 Bn | 325.50 Mn | 2.72 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 28, 2026 | 2.72 Bn |
| Dec 31, 2025 | 3.69 Bn |
| Sep 27, 2025 | 4.46 Bn |
| Jun 28, 2025 | 4.42 Bn |
| Mar 29, 2025 | 4.34 Bn |
| Dec 31, 2024 | 4.44 Bn |
| Sep 28, 2024 | 4.56 Bn |
| Jun 29, 2024 | 4.62 Bn |
| Mar 30, 2024 | 4.73 Bn |
| Dec 31, 2023 | 4.75 Bn |
| Sep 30, 2023 | 4.79 Bn |
| Jul 1, 2023 | 4.84 Bn |
| Apr 1, 2023 | 4.84 Bn |
| Dec 31, 2022 | 4.72 Bn |
| Oct 1, 2022 | 4.73 Bn |
| Jul 2, 2022 | 4.98 Bn |
| Apr 2, 2022 | 5.13 Bn |
| Dec 31, 2021 | 5.17 Bn |
| Oct 2, 2021 | 5.35 Bn |
| Jul 3, 2021 | 5.53 Bn |